Release source file to jitpack

For a complete list of all changes:
1.2.1...1.2.2

Minor Updates

For a complete list of all changes:
1.2.0...1.2.1

May 9, 2019 Updates

• Updated Actionable Genes for Solid Tumors
• Addition of Actionable Genes for Hematologic Malignancies
• Addition of 37 new heme- or fusion-associated genes
• Standardization of therapeutic names with NCI thesaurus

Data Release v1.20

v1.19 patch release

• KIT Exon 13 Mutations, KIT Exon 14 Mutations were removed from curation
• Updated NF1 summary

Data Release v1.19_patch_1

Change underscore to lodash & Bug fixes

Merge pull request #258 from zhx828/bug-fix

 Change underscore to lodash & Bug fixes

Change to HTML5Mode

update link

Signed-off-by: Hongxin Zhang <hongxin@cbio.mskcc.org>

January 24, 2019 Updates

• Lorlatinib FDA-approval in ALK-positive metastatic NSCLC added as a new Level 1 association.
• Addition of 16 new heme-associated genes

Data Release v1.19

December 14, 2018 Updates

• Inclusion of NTRK1 and NTRK3 Level R2 alterations to the Actionable Genes page
• Updated actionable genes table.
• Addition of 25 new heme-associated genes

Data Release v1.18

November 2, 2018 Updates

LOXO-292 for RET fusion–positive non–small cell lung cancer (NSCLC) added.

Data Release v1.17_patch_1

October 26, 2018 Updates

• Level R2 alterations in ALK, EGFR, and MET are now included in the Actionable Genes page
• Updated actionable genes table.
• Addition of 9 new heme-associated genes
• OncoTree updated from version 2017_06_21 to version 2018_06_15

Data Release v1.17